At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 101 enrolled
Drug / intervention
Ropivacaine 0.1% Injectable Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial of Combined Spinal Epidural Versus Dural Puncture Epidural Techniques for Labor Analgesia
In Brief
A Phase 4 clinical trial evaluating Ropivacaine 0.1% Injectable Solution and Bupivacaine 0.25% Injectable Solution for Labor Pain. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The primary purpose of this study is to determine if there are differences in block quality between the CSE and DPE techniques for labor analgesia in parturients in active labor. We hypothesize that when compared to the CSE technique, the DPE technique will significantly improve block quality in this population and require fewer "top-ups" and catheter replacements.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLabor Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartNov 2021
Primary CompletionDec 2023
TodayJul 2026
First PostedOct 6, 2021
Enrollment StartNov 21, 2021
Primary CompletionDec 7, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.7 years ago
Interventions
Ropivacaine 0.1% Injectable Solutiondrug
DPE
Bupivacaine 0.25% Injectable Solutiondrug
CSE